Analyst Activity – BTIG Research Reiterates Hold on Celgene (NASDAQ:CELG)

ME Staff
-
0

Analyst Ratings For Celgene (NASDAQ:CELG)

Today, BTIG Research reiterated its Hold rating on Celgene (NASDAQ:CELG).

Some recent analyst ratings include

  • 1/23/2018-BTIG Research Reiterated Rating of Hold.
  • 1/18/2018-Piper Jaffray Companies Reiterated Rating of Hold.
  • 1/17/2018-Mizuho Reiterated Rating of Buy.
  • 1/10/2018-Guggenheim Reiterated Rating of Buy.

Recent Insider Trading Activity For Celgene (NASDAQ:CELG)
Celgene (NASDAQ:CELG) has insider ownership of 0.95% and institutional ownership of 79.54%.

  • On 9/25/2017 Terrie Curran, Insider, sold 1,727 with an average share price of $143.89 per share and the total transaction amounting to $248,498.03.
  • On 9/12/2017 Gilla Kaplan, Director, sold 9,250 with an average share price of $141.56 per share and the total transaction amounting to $1,309,430.00.
  • On 9/5/2017 Michael D Casey, Director, sold 9,250 with an average share price of $139.03 per share and the total transaction amounting to $1,286,027.50.
  • On 8/10/2017 Ernest Mario, Director, sold 18,506 with an average share price of $130.52 per share and the total transaction amounting to $2,415,403.12.
  • On 8/2/2017 Gilla Kaplan, Director, sold 7,500 with an average share price of $134.52 per share and the total transaction amounting to $1,008,900.00.
  • On 6/26/2017 James J Loughlin, Director, sold 18,500 with an average share price of $133.57 per share and the total transaction amounting to $2,471,045.00.
  • On 6/22/2017 Michael A Friedman, Director, sold 10,000 with an average share price of $132.50 per share and the total transaction amounting to $1,325,000.00.

Recent Trading Activity for Celgene (NASDAQ:CELG)
Shares of Celgene closed the previous trading session at 104.00 up +1.09 1.06% with 103.0 shares trading hands.